Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hai-Xiang Sun

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Clinical and Translational Medicine|August 2, 2024
Anlotinib potentiates anti-PD1 immunotherapy via transferrin receptor-dependent CD8<sup>+</sup> T-cell infiltration in hepatocellular carcinomaFei Song, Bo Hu, Xiao-Liang Liang, et al.
Journal of Cancer|March 24, 2020
MicroRNA-19a-3p regulates cell growth through modulation of the PIK3IP1-AKT pathway in hepatocellular carcinomaHai-Xiang Sun, Zhang-Fu Yang, Wei-Guo Tang, et al.
Liver Cancer|April 17, 2025
<sup>18</sup>F-FDG PET/CT Predicts the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Liver TransplantationWen-Jing Zheng, Yang Xu, Hui Tan, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 7, 2019
Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinomaRui Peng, Peng-Fei Zhang, Xuan Yang, et al.
Oncotarget|April 29, 2017
HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinomaWei-Min Wang, Yang Xu, Yao-Hui Wang, et al.
Journal of Cellular Biochemistry|October 29, 2018
New insight into BIRC3: A novel prognostic indicator and a potential therapeutic target for liver cancerPei-Yao Fu, Bo Hu, Xiao-Lu Ma, et al.
Hepatology (Baltimore, Md.)|December 6, 2012
Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathwayHai-Xiang Sun, Yang Xu, Xin-Rong Yang, et al.
Zoological Research|July 25, 2025
Subcutaneous delivery of icariin via a gelatin methacryloyl (GelMA) hydrogel sustained-release system improves ovarian function in reproductively aged miceJia-Lian Mao, Xiang-Yi Wu, Ling-Xi Li, et al.
Molecular Oncology|September 20, 2021
Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective studyGui-Qi Zhu, Wei-Ren Liu, Zheng Tang, et al.
Journal for Immunotherapy of Cancer|May 4, 2026
Patient-derived organotypic tumor spheroids as a functional platform for predicting immunotherapeutic responses and guiding precision treatment for hepatocellular carcinomaFei Song, Yi-Jun Lu, Hai-Xiang Sun, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Clinical and Translational Medicine|August 2, 2024
Anlotinib potentiates anti-PD1 immunotherapy via transferrin receptor-dependent CD8<sup>+</sup> T-cell infiltration in hepatocellular carcinomaFei Song, Bo Hu, Xiao-Liang Liang, et al.
Journal of Cancer|March 24, 2020
MicroRNA-19a-3p regulates cell growth through modulation of the PIK3IP1-AKT pathway in hepatocellular carcinomaHai-Xiang Sun, Zhang-Fu Yang, Wei-Guo Tang, et al.
Liver Cancer|April 17, 2025
<sup>18</sup>F-FDG PET/CT Predicts the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Liver TransplantationWen-Jing Zheng, Yang Xu, Hui Tan, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 7, 2019
Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinomaRui Peng, Peng-Fei Zhang, Xuan Yang, et al.
Oncotarget|April 29, 2017
HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinomaWei-Min Wang, Yang Xu, Yao-Hui Wang, et al.
Journal of Cellular Biochemistry|October 29, 2018
New insight into BIRC3: A novel prognostic indicator and a potential therapeutic target for liver cancerPei-Yao Fu, Bo Hu, Xiao-Lu Ma, et al.
Hepatology (Baltimore, Md.)|December 6, 2012
Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathwayHai-Xiang Sun, Yang Xu, Xin-Rong Yang, et al.
Zoological Research|July 25, 2025
Subcutaneous delivery of icariin via a gelatin methacryloyl (GelMA) hydrogel sustained-release system improves ovarian function in reproductively aged miceJia-Lian Mao, Xiang-Yi Wu, Ling-Xi Li, et al.
Molecular Oncology|September 20, 2021
Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective studyGui-Qi Zhu, Wei-Ren Liu, Zheng Tang, et al.
Journal for Immunotherapy of Cancer|May 4, 2026
Patient-derived organotypic tumor spheroids as a functional platform for predicting immunotherapeutic responses and guiding precision treatment for hepatocellular carcinomaFei Song, Yi-Jun Lu, Hai-Xiang Sun, et al.
Pageof 8